Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.
Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
Catheter Cardiovasc Interv. 2022 Jan 1;99(1):11-16. doi: 10.1002/ccd.29548. Epub 2021 Feb 10.
The willingness of interventional cardiologists to adopt innovation and implement changes in day-to-day practice has received limited study.
Online-based survey on learning and innovation: 38 questions were distributed via email list to interventional cardiologists.
The survey was distributed to 8,110 e-mails and completed by 621 (7.7%, 91.8% men, 60% in the 35 to 54-year-old age group). Of the respondents who perform coronary interventions, 45% perform >100 cases of noncomplex percutaneous coronary interventions per year and of the respondents who perform structural interventions, 15% perform more than >100 transcatheter aortic valve replacements per year. Most respondents (86.7%) rate themselves as highly likely/likely to introduce recently approved equipment in everyday practice and 47.5% have tried a new coronary guidewire in the past 6 months. The most common reasons for reluctance to use new equipment were high cost (64%) and uncertainty about whether it provides additional benefits compared with existing equipment (48.5%). Radial access in STEMI cases is always used by 43.6% of the respondents and 55% always use radial access for coronary angiography. Of those who use femoral access, 32% always use ultrasound guidance and 91% have used a closure device in the last 6 months. Most respondents (80%) read journals to keep up with current practice and believe that the most effective way to learn is through attendance of workshops/short courses (77.5%). Most respondents (69%) are involved in research.
Interventional cardiologists who participated in the survey are highly likely to adopt innovation in daily clinical practice.
介入心脏病学家采用创新和实施日常实践变革的意愿受到的关注有限。
基于网络的学习和创新调查：通过电子邮件列表向介入心脏病学家分发了 38 个问题。
该调查分发给 8110 封电子邮件，有 621 名（7.7%，91.8%为男性，60%在 35 至 54 岁年龄组）医生完成了调查。在进行冠状动脉介入治疗的受访者中，45%每年进行>100 例非复杂经皮冠状动脉介入治疗，在进行结构性介入治疗的受访者中，15%每年进行>100 例经导管主动脉瓣置换术。大多数受访者（86.7%）表示自己极有可能/有可能将最近批准的设备引入日常实践，47.5%在过去 6 个月内尝试过新的冠状动脉导丝。不愿使用新设备的最常见原因是成本高（64%）和不确定与现有设备相比是否提供额外的益处（48.5%）。在 STEMI 患者中，43.6%的受访者始终使用桡动脉入路，55%的患者始终在冠状动脉造影中使用桡动脉入路。在使用股动脉入路的患者中，32%始终使用超声引导，91%在过去 6 个月内使用过闭合装置。大多数受访者（80%）通过阅读期刊来跟上当前的实践，并认为最有效的学习方式是参加研讨会/短期课程（77.5%）。大多数受访者（69%）参与研究。
参与调查的介入心脏病学家极有可能在日常临床实践中采用创新。
